<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen AA</submitter><funding>NIEHS NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>977-81</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2691140</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(6)</volume><pubmed_abstract>Human papillomavirus (HPV) type 16 infection is an etiologic factor in a subset of head and neck squamous cell carcinomas (HNSCC). It is unknown if host genetic susceptibility modifies the HPV16-HNSCC association. DNA samples collected as part of a Boston area case-control study of HNSCC were genotyped for single-nucleotide polymorphisms (SNPs) from the National Cancer Institute's SNP500Cancer database. Analysis of demographic, phenotypic and genotypic data for 319 HNSCC cases and 495 frequency-matched controls was performed using unconditional logistic regression. All reported P-values are two sided. We identified a polymorphism in the sodium-dependent vitamin C transporter SLC23A2 that modifies the risk of HNSCC associated with HPV16 infection. Among those with a wild-type allele at SLC23A2, the risk of HNSCC associated with HPV16-positive serology was 5.0 (95% confidence interval (CI) = 3.2-7.8). However, among those with a homozygous variant genotype, the risk of HNSCC associated with HPV16 was attenuated [odds ratio (OR) = 2.8; 95% CI = 1.2-6.2]. Further, when we tested whether genotype modified the interaction between citrus exposure, HPV16, and HNSCC, we found a dramatically increased risk of HNSCC for those with a wild-type SLC23A2 allele, HPV16-positive serology and high citrus intake (OR = 7.4; 95% CI = 3.6-15.1). These results suggest that SLC23A2 genetic variation alters HPV16-associated HNSCC while also highlighting the important role of citrus exposure in this disease.</pubmed_abstract><journal>Carcinogenesis</journal><pubmed_title>Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.</pubmed_title><pmcid>PMC2691140</pmcid><funding_grant_id>T32 ES07155</funding_grant_id><funding_grant_id>R01 CA100679</funding_grant_id><funding_grant_id>T32 ES007155</funding_grant_id><funding_grant_id>CA100679</funding_grant_id><funding_grant_id>R01 CA078609</funding_grant_id><funding_grant_id>CA78609</funding_grant_id><funding_grant_id>T32 CA 09001</funding_grant_id><pubmed_authors>Marsit CJ</pubmed_authors><pubmed_authors>Smith JF</pubmed_authors><pubmed_authors>Bryan JT</pubmed_authors><pubmed_authors>McClean MD</pubmed_authors><pubmed_authors>Posner MR</pubmed_authors><pubmed_authors>Houseman EA</pubmed_authors><pubmed_authors>Chen AA</pubmed_authors><pubmed_authors>Christensen BC</pubmed_authors><pubmed_authors>Kelsey KT</pubmed_authors><pubmed_authors>Nelson HH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.</name><description>Human papillomavirus (HPV) type 16 infection is an etiologic factor in a subset of head and neck squamous cell carcinomas (HNSCC). It is unknown if host genetic susceptibility modifies the HPV16-HNSCC association. DNA samples collected as part of a Boston area case-control study of HNSCC were genotyped for single-nucleotide polymorphisms (SNPs) from the National Cancer Institute's SNP500Cancer database. Analysis of demographic, phenotypic and genotypic data for 319 HNSCC cases and 495 frequency-matched controls was performed using unconditional logistic regression. All reported P-values are two sided. We identified a polymorphism in the sodium-dependent vitamin C transporter SLC23A2 that modifies the risk of HNSCC associated with HPV16 infection. Among those with a wild-type allele at SLC23A2, the risk of HNSCC associated with HPV16-positive serology was 5.0 (95% confidence interval (CI) = 3.2-7.8). However, among those with a homozygous variant genotype, the risk of HNSCC associated with HPV16 was attenuated [odds ratio (OR) = 2.8; 95% CI = 1.2-6.2]. Further, when we tested whether genotype modified the interaction between citrus exposure, HPV16, and HNSCC, we found a dramatically increased risk of HNSCC for those with a wild-type SLC23A2 allele, HPV16-positive serology and high citrus intake (OR = 7.4; 95% CI = 3.6-15.1). These results suggest that SLC23A2 genetic variation alters HPV16-associated HNSCC while also highlighting the important role of citrus exposure in this disease.</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Jun</publication><modification>2021-02-20T07:14:35Z</modification><creation>2019-03-27T00:22:46Z</creation></dates><accession>S-EPMC2691140</accession><cross_references><pubmed>19346260</pubmed><doi>10.1093/carcin/bgp076</doi></cross_references></HashMap>